CASALE, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 24.257
NA - Nord America 547
AS - Asia 115
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 24.924
Nazione #
IT - Italia 24.068
US - Stati Uniti d'America 547
CN - Cina 80
SE - Svezia 61
UA - Ucraina 43
DE - Germania 41
GB - Regno Unito 15
VN - Vietnam 12
FI - Finlandia 9
IN - India 9
SG - Singapore 6
BE - Belgio 4
FR - Francia 4
AU - Australia 3
ES - Italia 2
HK - Hong Kong 2
IQ - Iraq 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
NL - Olanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 24.924
Città #
Cagliari 23.979
Chandler 71
Nyköping 48
Fairfield 47
Ann Arbor 45
Woodbridge 45
Dearborn 32
Houston 32
Ashburn 29
Wilmington 23
New York 19
Seattle 18
Jacksonville 17
Shanghai 15
Boston 13
Cambridge 13
Dong Ket 12
Boardman 11
Nanjing 11
Beijing 10
San Mateo 7
Falls Church 6
Guangzhou 6
Nanchang 6
San Diego 5
Sìnnai 5
Washington 5
Atlanta 4
Brussels 4
Helsinki 4
Kunming 4
Norwalk 4
Santadi 4
Sassari 4
Changsha 3
Jiaxing 3
Mountain View 3
Pune 3
Taizhou 3
Tianjin 3
Bengaluru 2
Bitonto 2
Brescia 2
Chengdu 2
Frignano 2
Hefei 2
Hong Kong 2
Leawood 2
Martin de la Jara 2
Ningbo 2
Paris 2
Quartu Sant'elena 2
Redmond 2
Redwood City 2
Rome 2
Shenyang 2
Sydney 2
Amsterdam 1
Augusta 1
Azor 1
Belgrade 1
Bratislava 1
Chiswick 1
Christiansburg 1
Dolianova 1
Dolovo 1
Hebei 1
Jinan 1
London 1
Longmont 1
Madison 1
Monmouth Junction 1
Mumbai 1
Newcastle upon Tyne 1
Olmedo 1
Phoenix 1
Prescot 1
Putignano 1
San Gavino Monreale 1
San Sperate 1
Shaoxing 1
Simi Valley 1
Sohag 1
Trebaseleghe 1
Wandsworth 1
Wuhan 1
Zhengzhou 1
Zonguldak 1
Zurich 1
Totale 24.642
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.049
Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis: a possible pathogenetic role ? 3.003
Role of interferon lambda 4 and ALT levels in optimising treatment of HCV for patients with low-stage fibrosis 2.634
Impact of natural killer (NK) cells receptors gene haplotypes on the development of hepatocarcinoma in cirrhotic patients 2.456
Combination of IFNL4 polymorphisms and ALT reduction at 4 week of treatment with PEG IFN and Ribavirin is a new selection tool to optimize antiviral treatment allocation in HCV patients with low stage fibrosis 2.420
FATTORI IMPLICATI NELLA STORIA NATURALE DELL'INFEZIONE DA VIRUS DELTA:IL RUOLO DEGLI INTERFERONI 2.293
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.159
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.140
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 1.935
Efficacy and tolerability of treatment with the new direct acting antivirals (DAAs) in thalassemic patients with chronic Hepatitis 1.715
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 167
Totale 24.971
Categoria #
all - tutte 28.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019227 0 0 0 0 0 0 0 0 0 67 69 91
2019/20206.245 232 124 20 45 2.422 1.882 937 136 89 85 72 201
2020/20218.474 190 377 346 2.816 1.583 872 433 470 241 496 428 222
2021/20221.282 188 121 41 117 126 85 63 53 166 123 109 90
2022/20231.537 113 240 264 123 133 97 55 106 97 114 122 73
2023/20241.371 65 207 74 152 143 237 221 103 89 80 0 0
Totale 24.971